273 related articles for article (PubMed ID: 23801858)
1. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
[TBL] [Abstract][Full Text] [Related]
2. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
Kodar K; Kurtenkov O; Klaamas K
Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583
[TBL] [Abstract][Full Text] [Related]
3. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
Kurtenkov O; Izotova J; Klaamas K; Sergeyev B
Biomed Res Int; 2014; 2014():830847. PubMed ID: 25276822
[TBL] [Abstract][Full Text] [Related]
4. Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance.
Kurtenkov O; Klaamas K
Biomed Res Int; 2017; 2017():6097647. PubMed ID: 28316982
[TBL] [Abstract][Full Text] [Related]
5. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients.
Kurtenkov O; Bubina M; Klaamas K
Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973
[TBL] [Abstract][Full Text] [Related]
6. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.
Kurtenkov O; Klaamas K
Dis Markers; 2015; 2015():761908. PubMed ID: 26663951
[TBL] [Abstract][Full Text] [Related]
7. An increased level of the Concanavalin A-positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA).
Klaamas K; Kodar K; Kurtenkov O
Neoplasma; 2008; 55(2):143-50. PubMed ID: 18237253
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival.
Kurtenkov O; Klaamas K; Mensdorff-Pouilly S; Miljukhina L; Shljapnikova L; Chuzmarov V
Acta Oncol; 2007; 46(3):316-23. PubMed ID: 17450466
[TBL] [Abstract][Full Text] [Related]
9. IgG Glycosylation Profiling of Peripheral Artery Diseases with Lectin Microarray.
Li S; Meng J; Xu F; Wang Q; Tian X; Li M; Zeng X; Hu C; Zheng Y
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233595
[TBL] [Abstract][Full Text] [Related]
10. The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients.
Smorodin E; Sergeyev B; Klaamas K; Chuzmarov V; Kurtenkov O
Int J Med Sci; 2013; 10(12):1674-82. PubMed ID: 24151439
[TBL] [Abstract][Full Text] [Related]
11. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
[TBL] [Abstract][Full Text] [Related]
12. The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer.
Kurtenkov O; Innos K; Sergejev B; Klaamas K
Biomed Res Int; 2018; 2018():9579828. PubMed ID: 30105268
[TBL] [Abstract][Full Text] [Related]
13. Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.
Xu PC; Gou SJ; Yang XW; Cui Z; Jia XY; Chen M; Zhao MH
BMC Immunol; 2012 Mar; 13():10. PubMed ID: 22404873
[TBL] [Abstract][Full Text] [Related]
14. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
[TBL] [Abstract][Full Text] [Related]
15. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
Stümer J; Biermann MHC; Knopf J; Magorivska I; Kastbom A; Svärd A; Janko C; Bilyy R; Schett G; Sjöwall C; Herrmann M; Muñoz LE
Clin Exp Immunol; 2017 Sep; 189(3):372-382. PubMed ID: 28509333
[TBL] [Abstract][Full Text] [Related]
16. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease.
Shinzaki S; Kuroki E; Iijima H; Tatsunaka N; Ishii M; Fujii H; Kamada Y; Kobayashi T; Shibukawa N; Inoue T; Tsujii M; Takeishi S; Mizushima T; Ogata A; Naka T; Plevy SE; Takehara T; Miyoshi E
Inflamm Bowel Dis; 2013 Feb; 19(2):321-31. PubMed ID: 23287897
[TBL] [Abstract][Full Text] [Related]
17. Better survival of Helicobacter pylori infected patients with early gastric cancer is related to a higher level of Thomsen-Friedenreich antigen-specific antibodies.
Kurtenkov O; Klaamas K; Sergeyev B; Chuzmarov V; Miljukhina L; Shljapnikova L
Immunol Invest; 2003 Feb; 32(1-2):83-93. PubMed ID: 12722944
[TBL] [Abstract][Full Text] [Related]
18. Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients.
Zeng X; Li S; Tang S; Li X; Zhang G; Li M; Zeng X; Hu C
Front Immunol; 2021; 12():669137. PubMed ID: 34248947
[TBL] [Abstract][Full Text] [Related]
19. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
[TBL] [Abstract][Full Text] [Related]
20. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals.
Klaamas K; Kurtenkov O; Rittenhouse-Olson K; Brjalin V; Miljukhina L; Shljapnikova L; Engstrand L
Immunol Invest; 2002; 31(3-4):191-204. PubMed ID: 12472179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]